Which IV iron works best for anemia in pregnancy? a Head-to-Head trial
NCT ID NCT07721519
First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This trial compares two intravenous iron treatments—ferric carboxymaltose and iron sucrose—in pregnant women with iron deficiency anemia who need IV iron. Researchers want to see which one raises hemoglobin levels more after four weeks and whether one reduces hospital visits and improves satisfaction. Four hundred women in their second or third trimester will be randomly assigned to receive either treatment, with follow-up blood tests and surveys.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- intravenous ferric carboxymaltose (FCM) and intravenous iron sucrose (IS)
- What this could lead to
- If one iron treatment proves more effective, it could reduce the number of hospital visits needed and improve quality of life for pregnant women with severe anemia.
- What could go wrong
- This is a mid-sized trial in a specific population (Kurdish pregnant women), so results may not apply broadly. Both drugs carry risks like allergic reactions or infusion-site issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRON DEFICIENCY ANEMIA IN PREGNANCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••